Drug Shortage Report for MYLAN-OLANZAPINE ODT
Report ID | 9158 |
Drug Identification Number | 02382725 |
Brand name | MYLAN-OLANZAPINE ODT |
Common or Proper name | OLANZAPINE ODT |
Company Name | MYLAN PHARMACEUTICALS ULC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | OLANZAPINE |
Strength(s) | 15MG |
Dosage form(s) | TABLET (ORALLY DISINTEGRATING) |
Route of administration | ORAL |
Packaging size | 30BL |
ATC code | N05AH |
ATC description | ANTIPSYCHOTICS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2017-05-01 |
Estimated end date | Unknown |
Actual end date | 2017-07-12 |
Shortage status | Resolved |
Updated date | 2017-07-17 |
Company comments | This product is discontinued and reported under discontinuation ID 16015. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2017-07-17 | French | Compare |
v4 | 2017-07-17 | English | Compare |
v3 | 2017-05-05 | French | Compare |
v2 | 2017-05-05 | English | Compare |
v1 | 2017-05-05 | English | Compare |
Showing 1 to 5 of 5